Encouraging more substituted dispensing

Published: 2003-02-18 06:59:00

Updated: 2003-02-18 06:59:00

The KFDA suggested the MOHW to ease the current restricted provisions over the substituted dispensing especially for the drug proven of its bio-equivalency on occasion of their ordinary administration report to the National Assembly Health and Welfare Committee scheduled on Feb. 13 for the purpo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK